Update of ACR guidelines for osteoarthritis: role of the coxibs (Q43981433)

28 November 2017

Update of ACR guidelines for osteoarthritis: role of the coxibs (English)

1 reference

28 November 2017

0 references

Thomas J Schnitzer

1

1 reference

PubMed ID

11992747

28 November 2017

American College of Rheumatology

series ordinal

2

1 reference

28 November 2017

1 April 2002

1 reference

Journal of Pain and Symptom Management

28 November 2017

1 reference

28 November 2017

23

1 reference

28 November 2017

4 Suppl

1 reference

28 November 2017

S24-30; discussion S31-4

1 reference

Guidelines for the medical management of osteoarthritis

28 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900372-X

7 January 2021

Guidelines for the medical management of osteoarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900372-X

7 January 2021

Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900372-X

7 January 2021

Nonsteroidal anti-inflammatory drug use and death from peptic ulcer in elderly persons

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900372-X

7 January 2021

The role of nitric oxide in articular cartilage breakdown in osteoarthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900372-X

7 January 2021

A novel mechanism of action of tetracyclines: effects on nitric oxide synthases

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900372-X

7 January 2021

Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900372-X

7 January 2021

Users' guides to the medical literature: XVI. How to use a treatment recommendation. Evidence-Based Medicine Working Group and the Cochrane Applicability Methods Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900372-X

7 January 2021

A randomized trial comparing aerobic exercise and resistance exercise with a health education program in older adults with knee osteoarthritis. The Fitness Arthritis and Seniors Trial (FAST).

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900372-X

7 January 2021

Improvements in quadriceps sensorimotor function and disability of patients with knee osteoarthritis following a clinically practicable exercise regime.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900372-X

7 January 2021

North of England evidence based guideline development project: summary guideline for non-steroidal anti-inflammatory drugs versus basic analgesia in treating the pain of degenerative arthritis. The North of England Non-Steroidal Anti-Inflammatory Dr

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900372-X

7 January 2021

Preference for nonsteroidal antiinflammatory drugs over acetaminophen by rheumatic disease patients: a survey of 1,799 patients with osteoarthritis, rheumatoid arthritis, and fibromyalgia

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900372-X

7 January 2021

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900372-X

7 January 2021

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900372-X

7 January 2021

Comparison of the effect of rofecoxib (a cyclooxygenase 2 inhibitor), ibuprofen, and placebo on the gastroduodenal mucosa of patients with osteoarthritis: a randomized, double-blind, placebo-controlled trial. The Rofecoxib Osteoarthritis Endoscopy M

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900372-X

7 January 2021

A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2-specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis. Rofecoxib Osteoarthritis Endoscopy Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900372-X

7 January 2021

Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900372-X

7 January 2021

Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900372-X

7 January 2021

Risk for Serious Gastrointestinal Complications Related to Use of Nonsteroidal Anti-inflammatory Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900372-X

7 January 2021

Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation: an overview of epidemiologic studies published in the 1990s

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900372-X

7 January 2021

A guideline for the treatment and prevention of NSAID-induced ulcers. Members of the Ad Hoc Committee on Practice Parameters of the American College of Gastroenterology

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900372-X

7 January 2021

Potentiation of oral anticoagulation and hemarthrosis associated with nabumetone

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900372-X

7 January 2021

Interaction between Oral Anti-Coagulant Drugs and Non-Steroidal Anti-Inflammatory Agents: A Review

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900372-X

7 January 2021

Effects of nonsteroidal anti-inflammatory therapy on platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900372-X

7 January 2021

Effects of nonsteroidal antiinflammatory drugs on platelet function and systemic hemostasis

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900372-X

7 January 2021

Effect of nabumetone on hemostasis during arthroscopic knee surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900372-X

7 January 2021

Drug interaction with coumarin derivative anticoagulants. Standing Advisory Committee for Haematology of the Royal College of Pathologists

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900372-X

7 January 2021

Effect of combined anticoagulation and low-dose aspirin treatment on upper gastrointestinal bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900372-X

7 January 2021

Misoprostol dosage in the prevention of nonsteroidal anti-inflammatory drug-induced gastric and duodenal ulcers: a comparison of three regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900372-X

7 January 2021

Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900372-X

7 January 2021

Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900372-X

7 January 2021

Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non-steroidal anti-inflammatory drug therapy. A Nordic multicentre study

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900372-X

7 January 2021

Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900372-X

7 January 2021

A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900372-X

7 January 2021

Effects of nonsteroidal anti-inflammatory drugs on renal function: focus on cyclooxygenase-2-selective inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900372-X

7 January 2021

Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900372-X

7 January 2021

Renal safety and tolerability of celecoxib, a novel cyclooxygenase-2 inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900372-X

7 January 2021

Nonsteroidal anti-inflammatory drugs and hypertension. The risks in perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900372-X

7 January 2021

Nonsteroidal anti-inflammatory drugs (NSAIDs) and blood pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900372-X

7 January 2021

Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900372-X

7 January 2021

A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900372-X

7 January 2021

The impact of nonsteroidal anti-inflammatory drugs on hypertension: alternative analgesics for patients at risk.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900372-X

7 January 2021

Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900372-X

7 January 2021

NSAIDs associated with increased risk of congestive heart failure in elderly patients taking diuretics.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900372-X

7 January 2021

Consumption of NSAIDs and the development of congestive heart failure in elderly patients: an underrecognized public health problem.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900372-X

7 January 2021

The management of chronic pain in older persons: AGS Panel on Chronic Pain in Older Persons. American Geriatrics Society

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900372-X

7 January 2021

10.1016/S0885-3924(02)00372-X

Identifiers

DOI

1 reference

28 November 2017

1 reference

PubMed ID

11992747